4//SEC Filing
BAKEWELL JOHN K 4
Accession 0000950170-24-063617
CIK 0001630627other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:30 PM ET
Size
9.2 KB
Accession
0000950170-24-063617
Insider Transaction Report
Form 4
BAKEWELL JOHN K
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-05-21+33,260→ 33,260 totalExercise: $4.97Exp: 2034-05-21→ Common Stock (33,260 underlying) - Award
Common Stock
2024-05-21+15,091→ 150,139 total
Holdings
- 92,300(indirect: By Trust)
Common Stock
- 250,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date.
- [F2]Includes 15,091 restricted stock units.
- [F3]The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.
Documents
Issuer
TREACE MEDICAL CONCEPTS, INC.
CIK 0001630627
Entity typeother
Related Parties
1- filerCIK 0001183553
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:30 PM ET
- Size
- 9.2 KB